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Emerging evidence from high-income countries shows that
ethnic minority populations, which include diverse groups of
migrants, may be more reluctant than others to accept a vaccine
against coronavirus disease 2019 (COVID-19).1–3 One UK study
(n = 11 708), for example, found COVID-19 vaccine hesitancy—
a reluctance or refusal to vaccinate despite the availability of
vaccines—was the highest in Black ethnic groups, with 72%
reportedly unlikely or very unlikely to be vaccinated.3 Vaccine
hesitancy poses a threat for COVID-19 and control of all vaccine-
preventable diseases, and was considered one of WHO’s (World
Health Organization) top 10 global health threats in 2019.
Particular concerns are being raised around hesitancy and other
barriers to vaccination specifically in migrant groups (foreign-
born nationals), which are currently poorly elucidated. In
addition, large numbers of more recently arrived migrants remain
outside of health systems in many countries, due to, for example,
lack of legal entitlement, and thus risk being excluded from
vaccine roll-out. This includes undocumented migrants, asylum
seekers and refugees, those residing in camps, detention centres
and other high-risk settings, alongside specific communities
such as the Roma. It is important to act quickly upon these
issues, because migrants make up sizeable populations and
workforces in many high-income countries and have experienced
adverse clinical outcomes, including being disproportionately
represented in COVID-19 cases and deaths,4 ,5 and may need
to be targeted in vaccination campaigns.6 So, what are the risk
factors for under-immunization in migrant communities, and
how do we ensure better engagement and their inclusion in
national vaccine plans?
Multiple risk factors for under-immunization
Even before the pandemic, migrants were considered at risk
of under-immunization, with lower levels of routine vaccine
uptake and trust in vaccination compared with the general
population. As well as potential reluctance to vaccinate, migrants
face numerous, well-documented barriers to healthcare. Most
European countries, for example, restrict access to healthcare
and vaccination initiatives for certain migrant groups,7 which
has undoubtedly resulted in lower engagement with mainstream
services, despite the fact that ensuring high levels of coverage
and equitable access are key priorities of the WHO’s European
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Vaccine Action Plan and the Sustainable Development Goals.
Poor understanding of the host country’s health system, language
and cultural barriers and poor doctor–patient relationships com-
pound access issues. Some barriers may stem from longstanding
structural inequities, as well as the fact that these communities
tend to live in areas of higher deprivation. Ethnicity-related
factors, including religion, upbringing and beliefs also influence
immunization decisions.
Furthermore, these communities may be more susceptible to
COVID-19 vaccine misinformation, particularly where language
barriers and social exclusion contribute to a deficit of accurate
information.5 In a series of participatory community workshops
conducted with migrant community leaders in London,8 mistrust
and unwillingness to vaccinate for COVID-19 were reported,
with concerns raised about the extent of misleading COVID-19
vaccination information circulating in their communities via
social media (including TikTok, Facebook and Whatsapp) and
the perceived low representation of their communities in vaccine
trials. One qualitative study of refugees and asylum seekers found
they had a range of specific beliefs, including that COVID-19
is a ‘hoax’ or ‘Western disease’, or that it contains a microchip
to control the population5; other shared views include that the
vaccine will alter your DNA, may affect fertility or is not halal
(permitted by Islam). Migrants and clinicians reported concerns
that mistrust of the state and health system, stemming from
historical events, data sharing policies and dissatisfaction with
the initial handling of the pandemic, as well as low health literacy
in migrant communities and widespread vaccine misinformation,
have reinforced rumours and could negatively affect uptake
rates.5 ,8 Low levels of COVID-19 in migrants’ countries of origin
may also impact on their views on vaccination. Vaccination
coverage data disaggregated by migrant status are, however, lack-
ing in many health information systems, which has important
consequences for understanding inequities.
Experiences to date and policy response
to vaccine roll-out
Many governments did not include migrants and ethnic minori-
ties well in their national plans in the first wave of the pan-
demic,4 and it is crucial that we do not make the same mistakes
with vaccine roll-out. In a rapid review to assess COVID-19
communications targeting migrants (June 2020), for example,
only half of Council of Europe member states had translated
information into at least one foreign language, while 6% (3/47)
had translated information on testing or healthcare entitlements.
None produced risk communications on disease prevention for
refugee camps9; in the Greek camps hundreds of thousands of
migrants were excluded from the national response.10 Other
studies from Canada, Denmark and the US reported lags in
translating official guidance into foreign languages and poor
dissemination to, and hence access by, migrant communities;
importantly, groups with lower language and literacy levels were
also found to have lower testing rates.11 ,12 It is unsurprising,
therefore, that preliminary monitoring data suggest that some of
these communities are less likely to have been included in initial
vaccine roll-out.
A key priority now must be to identify ways to engage with
and deliver COVID-19 vaccination to marginalized migrants;
an issue likely to remain salient beyond these immediate few
months. There have been several positive developments. The
European Centre for Disease Prevention and Control (ECDC)
has classified migrants as potential target groups for vaccination
campaigns and advised that overcrowded settings (e.g. reception
centres, crowded housing and homeless shelters) are considered
when deciding upon priorities for vaccination.13 ,14 WHO also
identifies low-income migrant workers and irregular migrants
as priority groups globally. The IOM (UN Migration Agency)
has called on Member States to ensure all migrants, including
undocumented ones, are included in national vaccine deployment
plans. Some European governments have removed healthcare
entitlement barriers to testing and vaccination for COVID-19
or stated that vaccines will be available irrespective of residence
status (Spain, Netherlands, UK, France and Italy), whereas Ger-
many has prioritized asylum seekers living in accommodation
centres for vaccination. This alone is unlikely to encourage
widespread uptake, but is undoubtedly an important first step in
ensuring their inclusion, aligning with the principles of universal
health coverage and health equity. At the same time, it is worth
making a distinction between prioritization, and ensuring these
communities have access akin to the rest of the population, with
potential unintended consequences of prioritizing specific groups
such as migrants who, in some contexts, may find it stigmatising
and discriminatory; meanwhile, the native-born population may
perceive this as undue benefit. Instead, we should advocate for
these communities to be better considered within countries’
existing vaccine priority structures.
Co-producing solutions based on the principles
of inclusion and engagement
The next step is to ensure policy translates into practice, with
population diversity better recognized by policymakers. This will
require actively and meaningfully engaging with communities
to understand their concerns or barriers to vaccination and
working together to co-develop tailored approaches to encourage
uptake and rebuild trust. Participatory approaches, community
engagement and co-production, drawing on existing models of
best practice and expertise, will be critical—strategies previ-
ously called for by WHO and ECDC to strengthen vaccination
initiatives and, to some extent, reflected in WHO’s Tailoring
Immunization Programmes framework, which aims to address
barriers and leverage drivers of vaccination in populations with
sub-optimal vaccination uptake. These approaches offer a col-
laborative model of research, where researchers, social scientists,
community stakeholders and end-users work in partnership to
identify a problem and co-produce knowledge, empowering
communities to implement sustainable change. Recent studies
and discourse have recommended improved community out-
reach and engagement through a variety of platforms, settings
and messengers (e.g. opinion leaders and community champi-
ons), alongside greater consideration of the health, scientific
and general literacy levels in specific subpopulations. Outreach
efforts should also be complemented by longer-term strategies to
support and encourage underserved members of the community
to access health systems so they can be vaccinated.
Clear and concise written and visual resources for different
language/literacy needs should be developed, ideally centrally,
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Figure 1. Approaches and solutions for COVID-19 vaccine roll-out in migrant communities. Footnote: Adapted from Brewer et al15
with community representatives actively guiding their develop-
ment. They must be made available for local adaptation and
distribution, with the best channels for dissemination decided by
community members. Importantly, policymakers and researchers
must be prepared to hand over power and responsibility to
communities to lead inclusive, community-centred strategies for
increasing COVID-19 vaccination uptake, while recognising the
practical requirements and investment needed for co-production,
and nurturing and sustaining these relationships and systems so
that responses can be more efficiently mobilized in future public
health crises.
A WHO expert working group on behavioural and social
drivers of vaccination developed the ‘Increasing Vaccination
Model’ to establish the factors that influence vaccine uptake and
pinpoint specific areas for intervention, considering (i) the moti-
vation to get vaccinated (informed by feelings, emotions, social
norms and processes) and (ii) practical issues (e.g. access/avail-
ability, convenience, cost and service satisfaction).15 The extent
to which each driver contributes to low COVID-19 vaccination
uptake in migrants remains to be explored. In Figure 1, we show
how this model15 might be applied to strengthening COVID-19
vaccination uptake in these communities.
Opportunities and next steps
Routine and timely vaccination of at-risk groups should be an
urgent priority for any country that is serious about achieving
control of COVID-19, and other vaccine-preventable diseases. As
we seek to address the stark health inequalities exposed by this
pandemic, it is essential that we urgently strengthen engagement
and build trust with migrant communities and acquire a better
understanding of how to support them. At the heart of this
is ensuring they are more meaningfully included through more
culturally competent health systems, where greater emphasis is
placed on providing care to patients with diverse values and
behaviours and tailoring delivery to meet patients’ social, cultural
and linguistic needs.
Key messages and recommendations
• Ensure undocumented migrants, asylum seekers and
other excluded migrant populations—including those
residing in camps, reception and detention facilities—are
meaningfully included in COVID-19 vaccination roll-out
plans and supported to access health systems.
• Better consider migrants within the existing vaccine prior-
ity structure defined by individual countries, which may
require specific tailored and targeted approaches consid-
ering their specific risk factors for under-immunization.
• Urgently conduct more research to explore key risk fac-
tors for under-immunization for COVID-19 in these com-
munities, to assess the extent to which vaccine hesitancy
and circulating misinformation is playing a role and to
better elucidate physical and other structural barriers to
vaccination.
• Actively involve communities in the planning, co-
production, dissemination and implementation of tai-
lored and targeted approaches to encourage widespread
participation in COVID-19 vaccination programmes, and
empower migrant and minority healthcare profession-
als within communities. It is vital that local govern-
ment, public health teams and healthcare professionals
establish trust with communities and build partnerships
with local stakeholders through regular and meaningful
engagement activities.
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• Incentivise better recording of data or integrating core
variables around ethnicity and migration for vaccine
uptake into Health Information Systems, and strengthen
the evidence-base to support innovative interventions and
engagement around other vaccine-preventable diseases.
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